| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794982 | Ophthalmology Retina | 2017 | 9 Pages |
Abstract
Eyes with HE have larger choroidal neovascularization lesions and more RAP. Their initially thicker retina rapidly becomes thinner with anti-VEGF treatment. HE is not significantly associated with hyperlipidemia. HE at baseline does not significantly influence VA, scar, and geographic atrophy outcomes in eyes with NVAMD treated with anti-VEGF. Few eyes have HE at year 2.
Keywords
CNVNVAMDCATTRAPDMECSMEAMDRPEChoroidal neovascularizationgeographic atrophyfluorescein angiographyDiabetic macular edemaclinically significant macular edemaretinal pigment epitheliumOctOptical coherence tomographyretinal angiomatous proliferationVisual acuityneovascular age-related macular degenerationage-related macular degenerationVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)disc diameterhepatic lipaseLipcComparison of Age-Related Macular Degeneration Treatments Trialsdisc areaSingle nucleotide polymorphismSNP
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ebenezer MBBS, PhD, Juan E. MD, Benjamin J. MD, Maureen G. PhD, Glenn J. MD, Cynthia A. MD, Frederick L. MD, Daniel F. MD, James MS, Gui-Shuang PhD,